Perth-based pharmaceutical company AusCann announced that it has finalised the sale of the company’s right, title and interest in its 50% owned Chilean joint...
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.